These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime. Vallée F, LeBel M. Antimicrob Agents Chemother; 1991 Oct; 35(10):2057-64. PubMed ID: 1759827 [Abstract] [Full Text] [Related]
24. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test. Reller LB. Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219 [Abstract] [Full Text] [Related]
25. Synergistic activity of cefotaxime and desacetylcefotaxime against the Bacteroides fragilis group. Cornick NA, Gorbach SL. Diagn Microbiol Infect Dis; 1988 Jun; 10(2):81-4. PubMed ID: 3224498 [Abstract] [Full Text] [Related]
26. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction. Paap CM, Nahata MC, Mentser MA, Mahan JD, Puri SK, Hubbard JW. Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862 [Abstract] [Full Text] [Related]
27. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Trang JM, Jacobs RF, Kearns GL, Brown AL, Wells TG, Underwood FL, Kluza RB. Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862 [Abstract] [Full Text] [Related]
28. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients. Urien S, Laurent N, Barre J, Druguet M, Bouvier D'yvoire M, Maire P. Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629 [Abstract] [Full Text] [Related]
30. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime. Quintiliani R, Nightingale CH, Tilton R. Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220 [Abstract] [Full Text] [Related]
32. Pharmacokinetics of cefotaxime in neonatal pony foals. Gardner SY, Sweeney RW, Divers TJ. Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578 [Abstract] [Full Text] [Related]
33. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates. Piédrola G, Galan I, Leyva A, Maroto MC. Drugs; 1988 Apr; 35 Suppl 2():62-4. PubMed ID: 3135171 [Abstract] [Full Text] [Related]
34. Physiologically-Based Pharmacokinetic Modeling and Dosing Optimization of Cefotaxime in Preterm and Term Neonates. Li Q, Guan Y, Xia C, Wu L, Zhang H, Wang Y. J Pharm Sci; 2024 Aug; 113(8):2605-2615. PubMed ID: 38460573 [Abstract] [Full Text] [Related]
40. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid. Beyssac E, Cardot JM, Colnet G, Sirot J, Aiache JM. Eur J Drug Metab Pharmacokinet; 1987 Aug; 12(2):91-102. PubMed ID: 3691581 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]